INTRODUCTION
Largely uncharacterized substances in the plasma of uraemic patients have been reported to depress neutrophil (PMN) metabolism\respiratory burst (particularly, luminol-enhanced chemiluminescence and bacterial killing) [1] [2] [3] . Although the precise substance(s) in uraemic plasma responsible for diminished PMN chemiluminescence and bactericidal activity remain controversial [4, 5] , it has been repeatedly suggested that the high levels of urea in patients with renal failure might be involved. High concentrations of urea are also present in the urinary bladder, particularly in patients with urinary stasis, a recognized risk factor for urinary-tract infections. It has been speculated that these infections are promoted, in part, by constituents of urine that impair phagocyte activity. One possible inhibitory factor is the hyperosmolality of urine, which may inhibit PMN phagocytosis [6] and oxidative metabolism [7] without affecting PMN viability. However, increased osmolality from inorganic salts may be only partially responsible for inhibition of PMN oxidative activity (particularly as measured by luminol-enhanced chemiluminescence). In fact, Etzioni et al. [8] reported that urea, which can be present in urine in concentrations exceeding 500 mM, is more inhibitory of PMN chemiluminescence than is hyperosmolality caused by inorganic salts.
It occurred to us that the aforementioned inhibitory effects of urea on PMN function might not be due to urea per se. Under physiological conditions, cyanate (CNO − ) spontaneously forms from urea and reaches equilibrium in the molar ratio approx. 0n0075 : 1 (CNO\urea) [9] . CNO − , a nucleophile, reacts with amino and thiol groups of proteins, irreversibly and reversibly, Abbreviations used : DTNB, 5,5h-dithio-bis-(2-nitrobenzoic acid) ; HBSS, Hanks balanced-salt solution ; MPO, myeloperoxidase ; MTT, 3-(4,5-dimethylthiazo-2-yl)-2,5-diphenyltetrazolium bromide ; OZ, opsonized zymosan ; PMNs, polymorphonuclear neutrophils ; TNB, 5-thio-2-nitrobenzoic acid. 1 Present address : Princeton Biomeditech Corp., P.O. Box 7139, Princeton, NJ, U.S.A. 2 To whom correspondence should be addressed. 3 Deceased.
support of this, we find : (i) CNO − inhibits both peroxidative and halogenating activities of MPO and also inhibits the enzyme within intact human neutrophils ; (ii) the inhibition is H # O # -dependent, irreversible, accompanied by covalent addition of ["%C]CNO − (or a carbon-containing fragment thereof) to the enzyme ; (iii) CNO − also inhibits Cl − \H # O # \MPO-mediated bacterial killing. Impairment of this arm of neutrophil bactericidal activity by CNO − formed from urea may be one factor in the risk of urinary-tract infection associated with urinary stasis and perhaps in the generalized increase in susceptibility to infection in uraemic patients. through carbamoylation reactions [10] . In patients with chronic renal failure, PMN proteins are modified by CNO − in i o, and it has been suggested that this carbamoylation-mediated protein modification might contribute to PMN dysfunction [11] .
CNO − is chemically similar to thiocyanate (SCN − ), a so-called ' pseudohalide ', which can serve as substrate for peroxidases [such as lactoperoxidase, myeloperoxidase (MPO) and eosinophil peroxidase] yielding hypothiocyanous acid (HOSCN) [12] . Therefore we thought that CNO − also might act as a pseudohalide but that the product of an MPO-CNO − reaction, if any, might be relatively impotent at bacterial killing and\or might directly inhibit MPO.
The possibility that product(s) of MPO-CNO − reaction might hinder normal MPO activity was indirectly supported by the previously mentioned decreases, caused by constituents of normal urine, of luminol-enhanced chemiluminescence produced by activated PMNs [18] ; luminol-enhanced chemiluminescence reflects primarily MPO generation of hypochlorous acid (HOCl) [13] . The activity of MPO, which normally generates HOCl from Cl − and H # O # , is important in the bactericidal activity of PMN. Therefore we investigated the effects of CNO − on MPO activity, PMN oxidative metabolism, and MPO-mediated bactericidal activity. Overall, the results indicate that, particularly at the lower pH possible in urine, physiologically expectable concentrations of CNO − irreversibly inhibit MPO. This evidently occurs via a mechanism-based H # O # -dependent modification of MPO by CNO − . Such inhibition may help to explain the lack of effective host killing of pathogens within the urinary tract and perhaps the defective bacterial killing by PMNs from uraemic patients.
MATERIALS AND METHODS

Materials
All reagents, unless otherwise indicated, were purchased from Sigma Chemical Co., St. Louis, MO, U.S.A. Partially purified human MPO with an RZ value (A %#) \A #)! ) of 0n51 was a gift from Dr. Beulah Gray, University of Minnesota, Minneapolis, MN, U.S.A. The stock concentration was determined spectrophotometrically and calculated using a molar absorption coefficient of 89 mM −" :cm −" at 428 nm. The stock enzyme solution had a concentration of 0n5 mg of MPO\ml or 3n37 µmol\l MPO (as tetramer). With guaiacol as substrate (see peroxidase assay below), this enzyme preparation had an activity of 343 units\mg of total protein (1 unit l ∆A %(! of 1n0\min at pH 7n0 and 25 mC in a total volume of 3 ml). This definition of a unit is used throughout this paper. Dextran (3 %) in 0n89 % NaCl, and Percoll were obtained from Pharmacia Fine Chemicals (Uppsala, Sweden). Zymosan was washed with, and suspended in, PBS at 20 mg\ml. The zymosan was opsonized by incubation with an equal volume of fresh human serum for 30 min at 37 mC with shaking. The opsonized zymosan (OZ) was then washed twice with PBS, suspended at a density of 50 mg\ml and stored at k20 mC.
Neutrophil preparation
Human PMNs were obtained from heparinized venous blood of healthy volunteers by the technique of Redl et al. [14] . Briefly, fresh minimally heparinized venous blood was sedimented under unit gravity with 3 % dextran in 0n85 % NaCl and the supernatant was collected and centrifuged. Contaminating erythrocytes in cell pellets were lysed by brief exposure to ice-cold water after which isotonicity was rapidly restored. PMNs were separated by continuous gradient containing sterile iso-osmotic NaCl and Percoll with a density of 1n075. The PMNs were washed three times in Ca# + \Mg# + -free Hanks balanced-salt solution (HBSS) and resuspended in complete HBSS. The cell preparations usually contained more than 95 % PMNs, and cell viability was at least 98 % as determined by Trypan Blue exclusion.
Peroxidase assay
Peroxidase activities of MPO and PMN lysates were determined by guaiacol oxidation [15] . Reaction mixtures contained 50 mM sodium phosphate buffer, pH as indicated, 13n5 mM guaiacol and enzyme sources in a total volume of 1 ml. The reactions were initiated by adding 300 µM H # O # , and changes in A %(! were monitored over 3 min at 25 mC. Enzyme activity was expressed as the rate of absorbance increase per min.
HOSCN assay
The halogenation activity of MPO was determined by oxidation of the pseudohalide SCN − . In the presence of SCN − and H # O # , MPO catalyses the oxidation of SCN − to yield HOSCN or its conjugate base, hypothiocyanite (OSCN − ) (pK $ 5n3). HOSCN\ OSCN − are less reactive with most substrates than are hypochlorous acid\hypochlorite (HOCl\OCl − ) and do not require trapping (such as the use of added taurine to trap HOCl as taurine chloramine). Reactions were carried out as described above in the presence of 10 mM KSCN and in the absence of Cl − . HOSCN\OSCN − accumulation was detected by the method of Aune and Thomas [16] . Briefly, 5,5h-dithio-bis-(2-nitrobenzoic acid) (DTNB) was pre-reduced to 5-thio-2-nitrobenzoic acid (TNB) with 2-mercaptoethanol, in a molar ratio of 1 : 0n9, in 100 mM Na # PO % buffer containing 5 mM EDTA at pH 8n8, then the pH was adjusted to 7n0 with 100 mM NaH # PO % , pH 4n4. The amounts of TNB oxidized to DTNB by HOSCN\OSCN − were determined spectrophotometrically at 412 nm (assuming a molar absorption coefficient of 13 600 M −" :cm −" ).
Ascorbate oxidation
In the presence of Cl − and H # O # , MPO generates HOCl which,
, will oxidize ascorbate. Therefore, in welldefined systems (especially the absence of transition metals), oxidation of ascorbate can be used as a relatively sensitive and continuous indicator of HOCl formation [17] . The reaction mixtures contained 50 mM phosphate, 100 mM NaCl, 0n5 mM EDTA and 100 µM sodium ascorbate. The reaction was initiated by adding 300 µM H # O # , and ascorbate oxidation was monitored by decrease in A #'' over 3 min. The millimolar absorption coefficient of ascorbate is 15n0 mM −" :cm −" .
CNO − -mediated inactivation of MPO in intact PMNs
Purified PMNs (0n8i10' cells\ml) were suspended in complete HBSS containing 0n2 % BSA, pH 7n0. The cells were incubated with the indicated compounds at room temperature (20 mC) for 5 min, followed by the addition of 1 mM H # O # , 100 nM PMA or 0n2 mg\ml OZ (final concentrations) to the cell suspensions. The cells were then incubated for 30 min at 37 mC and pelleted by centrifugation at 12 000 g for 1 min. Cell pellets were lysed in 1 ml of 50 mM sodium phosphate, pH 7n0, with 0n2 % Triton4 X-100 and the lysates were sonicated in an ice bath for 1 min to release MPO from granules. Control experiments indicate that this procedure releases more than 95 % of total PMN MPO content. We should note that lysates prepared by the addition of cetrimide exhibited somewhat less MPO activity and contained precipitates so that Triton extraction was substituted. For comparison, PMN suspensions with identical treatment without the addition of H # O # or stimuli were incubated, pelleted and lysed under the same conditions. The residual MPO activities in the lysates were determined by guaiacol assay.
Reaction of [ 14 C]CNO − with MPO
Limited experiments were performed to determine whether CNO − might engage in an H # O # -dependent covalent reaction with MPO. For this, 20 µg of MPO in 50 mM sodium phosphate buffer, pH 7n0, was incubated with 0n5 µCi (10 nmol) of ["%C]CNO − (provided as KOCN ; specific radioactivity 48n3 µCi\µmol ; New England Nuclear) in the presence or absence of 1 mM H # O # in a total volume of 50 µl. After a 10 min incubation at 25 mC, 50 µl of 2isample buffer containing 2-mercaptoethanol (10 %), SDS and Bromophenol Blue was added and the samples were heated at 95 mC for 5 min. A 20 µl portion of this preparation was loaded per lane on SDS\polyacrylamide gels (10 %) run in a Mini-Protean2 II apparatus according to a standardized protocol (Bio-Rad Laboratories). The gels were stained for protein with Coomassie Blue and subjected to autoradiography.
Determination of CNO −
CNO − was assayed by reaction with 2-aminobenzoic acid followed by spectrophotometric determination of the product (quinazoline-2,4-dione) as described by Guilloton and Karst [18] . Briefly, CNO − -containing solutions were allowed to react with an excess of 2-aminobenzoic acid in 50 mM phosphate buffer, pH 4n4, at 40 mC for 10 min. After brief cooling to room temperature, an equal volume of 12 M HCl was added and the solutions were placed in a boiling water bath for 1 min. The resulting product, quinazoline-2,4-dione, was measured spectrophotometrically at 310 nm and calculated assuming a molar absorption coefficient of 3n56 M −" :cm −" (which was confirmed by a standard curve made with reagent KOCN).
Neutrophil-derived H 2 O 2 and HOCl production
Purified PMNs were suspended in complete HBSS buffered with added 10 mM sodium phosphate, pH 7n4. For H # O # assays, 1 mM NaN $ was added to 0n5i10' cells\ml (final volume 1 ml) to inhibit endogenous catalase and peroxidase activities. The cells were stimulated by addition of 100 nM PMA in the presence or absence of KOCN (added 5 min beforehand) and incubated at 37 mC for 1 h. Under these conditions, PMN generation of H # O # is known to be sustained for as long as 2 h [19] . The accumulated H # O # was determined by ferrithiocyanate as described previously [19] , with minor modifications [20] . Briefly, 200 µl of 50% icecold trichloroacetic acid was added to 1 ml of PMN suspensions and the proteins sedimented by brief (5 min) centrifugation at 10 000 g. Freshly prepared ferrous ammonium sulphate (100 µl of a 20 mM stock) was added to 800 µl of the supernatant, followed by 100 µl of 2n5 M KSCN. Absorbance of the ferrithiocyanate complex was measured spectrophotometrically at 480 nm, and H # O # concentration was calculated by comparison with a standard curve made with reagent H # O # . The reagent H # O # concentration was determined assuming a molar absorption coefficient of 81 M −" :cm −" at 240 nm [21] . For HOCl determinations, 15 mM taurine was added to 1i10' cells\ml to trap HOCl. The accumulated taurine chloramine was determined by reaction with KI and the I $ − was measured spectrophotometrically at 355 nm [22] . Other conditions were as described for assays of H # O # production.
Bactericidal activity
Staphylococcus aureus, a clinical isolate obtained from the Microbiology Laboratory at Albany Medical College, were maintained on standard blood-agar plates, and suspension cultures were grown in trypticase soy broth for 16 h at 37 mC before use in bactericidal assays. The organisms were washed with complete HBSS three times and resuspended in the same buffer. Density of the organisms was estimated turbidometrically (A &&! of 1n0 was assumed to equal 8n6i10) cells\ml). The diluted bacterial suspensions were pipetted into 96-well plates with a final density of 1i10( cells\well. Incubations with various oxidants and MPO were carried out in a total volume of 100 µl\well. All constituents of the incubation mixtures were prepared by dilution in complete HBSS. The plates were incubated at 37 mC for 10 min followed by the addition of 100 µl of trypticase soy broth with 25 µg\ml catalase to scavenge the residual oxidants. After 30 min, 50 µl of trypticase soy broth containing 25 µg of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was added and the incubation continued for an additional 90 min at 37 mC. Cumulative MTT reduction, a measure of bacterial viability, was determined spectrophotometrically at 550 nm with a Molecular Devices Thermomax plate reader after lysis of the cells and solubilization of the formazan with 50 µl of a solution containing 10 % SDS, 50 % dimethylformamide and 200 mM acetic acid [23] . The bactericidal activity was expressed as (A sample kA blank )\(A control kA blank )i100.
RESULTS
In the presence of H # O # , MPO oxidizes halides and pseudohalides, including Cl − , Br − , I − and SCN − , to the corresponding hypohalous acids. MPO also causes one-electron peroxidation of numerous electron donors such as guaiacol without the participation of halides. We used the guaiacol assay and an ascorbate-oxidation assay to investigate interactions of CNO − with MPO and to distinguish the possible effects of CNO − on the two activities of MPO, namely peroxidation and hypohalous acid production [24] .
CNO − -dependent inhibition of MPO-mediated peroxidation
As shown in Figure 1 , at neutral pH, CNO − inhibits MPOcatalysed guaiacol oxidation. Importantly, when the pH of the reaction buffer (50 mM sodium phosphate) is decreased, the inhibitory potency of CNO − increases substantially. In the broad range of physiologically possible pH, the IC &! values of CNO − for MPO are approx. 30n4, 63n2, 321n0 and 493n6 µM at pH 5n4, 6n2, 7n0 and 7n8, respectively. [We should mention that, although the optimal pH for the guaiacol assay is around 6, the apparent MPO-mediated reaction rate (in the absence of added CNO − ) decreases slightly from pH 6n2 to pH 7n8.] As detailed below, very similar results were obtained with a qualitatively different assay of MPO halogenating activity (ascorbate oxidation).
We further investigated the influence of the concentration of guaiacol on CNO − -mediated inhibition of MPO activity. In the presence of a constant concentration of H # O # (300 µM), the IC &! of CNO − decreases from 321 to 131 µM when the guaiacol concentration is lowered from 13n5 to 1n35 mM (Figure 2 ). Therefore the concentration of peroxidatic substrate affects CNO − inhibition of MPO, with higher concentrations of the electron donor guaiacol antagonizing CNO − inhibition. It should be noted that, when up to 1 % (w\v) BSA or 10 mM glycine is included in the assay mixture, the IC &! of CNO − for MPOcatalysed guaiacol oxidation is unaffected. This indirectly supports the idea that CNO − or its reactive intermediate selectively targets MPO rather than non-specifically reacting with all proteins in the mixture.
Figure 1 Inhibition of MPO by CNO − at various pH values
The peroxidase activity of MPO in the presence of KOCN was assayed by guaiacol as described in the Materials and methods section. Each assay mixture contained 17 m-units of MPO (as assayed by the standard guaiacol reaction at pH 7n0) in a total volume of 1 ml. Enzyme activity is expressed as percentage of controls (without KOCN) at each pH. The absolute activities of MPO observed at these different pH values were 47i10 − 3 , 55i10 − 3 , 50i10 − 3 and 47i10 − 3 ∆A/min (in a reaction volume of 1 ml) at pH 5n4, 6n2, 7n0 and 7n8 respectively. 
Figure 3 Effects of CNO − on MPO-catalysed HOSCN production
The reaction mixtures contained 10 mM KSCN as substrate, 50 m-units of MPO (as assayed by guaiacol) and 0n1 % BSA in 50 mM sodium phosphate buffer, pH 7n0 (total volume 1 ml). The reaction was initiated by adding 300 µM H 2 O 2 and stopped by adding 50 µg of catalase after 10 min incubation at 20 mC. The accumulated HOSCN/OSCN − was determined by TNB oxidation, as described in the Materials and methods section. HOSCN/OSCN − formation is expressed as percentage of control (without KOCN), which was 36n6 nmol/10 min.
CNO − -mediated inhibition of hypohalous acid production by MPO
When HOCl production was estimated using taurine chloramine formation, CNO − was also found to inhibit HOCl production (or perhaps taurine chloramine formation via an enzyme-bound chlorinating intermediate [25] ) by MPO with IC &! values similar to those observed for guaiacol oxidation (results not shown). We observed that NaOCl can react with CNO − but does not prevent the formation of taurine chloramine and does not react with the latter. However, as a further test of the inhibitory potency of CNO − , we took advantage of the fact that HOSCN does not react with CNO − and employed KSCN as substrate to examine the effects of CNO − on the halogenation activity of MPO by measuring HOSCN accumulation. As shown in Figure 3 , in the presence of 1 mM H # O # and 10 mM KSCN (pH 7n4), CNO − inhibits MPO-catalysed HOSCN formation. The approximate IC &! of CNO − for MPO under these conditions is about 500 µM, comparable with that obtained with both the guaiacol assay and (not shown) the taurine chloramine assay at this pH. These Reaction mixtures contained 100 µM sodium ascorbate, 0n5 mM EDTA, 100 mM NaCl and 50 mM sodium phosphate buffer with pH as indicated. The activities of MPO present were 8n5 m-units and 170 m-units, for pH 5n4 and pH 7n0 samples respectively. The decrease in A 266 (representing the oxidation of ascorbic acid to dehydroascorbate) was recorded over 3 min, at 20 mC, after addition of H 2 O 2 . Enzyme activity was expressed as percentage of control ascorbate oxidation without added KOCN. The MPO/Cl − -dependent ascorbate-oxidation rates in the absence of KOCN were about 5 nmol/min at pH 5n4 and 10 nmol/min at pH 7n0. Note that under these conditions (i.e. in the presence of Cl − ), MPO oxidizes ascorbate 40 times faster at pH 5n4 than at pH 7n0. Therefore, despite the large differences in amounts of MPO added, the actual rates of ascorbate oxidation in the absence of CNO − were 6n0 and 9n6 nmol/min per ml at pH 5n4 and 7n0 respectively.
results further indicate that concentrations of SCN − up to 10 mM are unable to competitively block CNO − -mediated inhibition of MPO. Furthermore CNO − inhibition of MPO is similar regardless of the alternative substrates employed.
CNO − also profoundly inhibits Cl − -dependent ascorbate oxidation at low concentrations (IC &! 8 and 51 µM at pH 5n4 and 7n0 respectively) ( Figure 4) . Although compound II of MPO can directly oxidize ascorbate without forming other reactive intermediates (e.g. HOCl [26] [27] [28] ), the rate of ascorbate oxidation is greatly accelerated in the presence of Cl − . Such Cl − -dependent ascorbate oxidation is due to HOCl formation [17] , and therefore reflects MPO-mediated HOCl production. With regard to the apparent inhibition of HOCl production, we are reasonably certain that the CNO − inhibition of this reaction is not an artifact resulting from the interception of HOCl by CNO − , under the same experimental conditions and in the presence of both CNO − and ascorbate, HOCl (10-100 µM) reacts stoichiometrically with ascorbate (i.e. not with CNO − ) even when concentrations of CNO − are 10-fold higher than ascorbate (100 µM-1 mM). A hypothetical oxidizing CNO − intermediate, if any is indeed formed by MPO, appears not to react with ascorbate because there is no detectable CNO − -dependent increase in ascorbate consumption in the presence or absence of Cl − .
Finally, when 100 µM CNO − is present in a system containing relatively large amounts of MPO (340 m-units of MPO, 300 µM H # O # , 50 mM phosphate, pH 7n0, in a total volume of 1 ml with the reaction proceeding for 15 min with or without 100 mM NaCl), there is no significant loss of CNO − [by direct measurements of residual CNO − after the incubation (results not shown)]. This indicates that MPO is unable to catalytically consume CNO − and, under these conditions, CNO − does not simply behave as an HOCl scavenger. Thus CNO − effectively inhibits both the peroxidatic and halogenating reactions of MPO and does so with approximately the same IC &! . Moreover, the inactivation appears to be irreversible because the inhibition of MPO activity persists after dilution of samples such that there is only 2-10 µM residual CNO − present (a concentration that does not affect guaiacol oxidation at pH 7n0). Overall, these results support the idea that CNO − inhibits MPO through a mechanism-based H # O # -dependent reaction rather than through simple carbamoylation of ε-amino or other functional groups of MPO (a reaction that should be unaffected by added H # O # ). The precise nature of the inhibitory reaction between MPO and CNO − remains uncertain. However, we do have evidence that CNO − prevents formation of the reactive MPO compound II (FeIV) intermediate. Thus, as shown in Figure 5 (A), ' resting ' MPO has the expected absorbance maximum at 428 nm which, on addition of H # O # , shifts to 454 nm (reflecting the formation of compound II [29, 30] ). In contrast, in the presence of added CNO − , this spectral shift is absent ( Figure 5B ). (It should be noted that the absorbance shift at 568 628 nm was also absent in the presence of CNO − .) In the presence of both H # O # and Cl − , MPO progressively loses the haem absorption peak at 400-450 nm, probably reflecting HOCl-dependent haem destruction. However, similar spectra recorded in a Cl − -containing system in the presence of CNO − displayed no loss of haem absorption (not shown). Overall, these results indicate that CNO − prevents formation of MPO compound II and, in a Cl − -containing system, may also prevent the formation of compound I. Finally, the inactivation of MPO by CNO − evidently involves formation of a covalent CNO − adduct with the enzyme. As would be expected, incubation of MPO or albumin with ["%C]CNO − leads to formation of small amounts of covalent adducts via non-oxidative carbamoylation. However, in the case of MPO, but not albumin, addition of H # O # causes a substantial increase in protein-associated radioactivity. Interestingly, as shown in Figure 6 , it is the larger (haem-containing) α-subunit of MPO that is preferentially labelled by [ 
Figure 7 Inactivation of MPO in intact neutrophils by KOCN
Purified human PMNs (0n8i10 6 /ml) were suspended in complete HBSS with added 10 mM phosphate, pH 7n0, without (open bars) or with 1 mM (hatched bars) or 4 mM (stippled bars) KOCN, and treated with H 2 O 2 (1 mM), PMA (100 nM) or OZ (0n2 mg/ml) for 30 min. The cells were pelleted and then lysed in 100 µl of 50 mM phosphate containing 0n2 % Triton X-100. Aliquots of the lysates (10 µl) were assayed for peroxidase activity by the guaiacol reaction. Each treatment was carried out in quadruplicate, and results are expressed as percentage of activity in cells incubated without any addition (meanspS.D.) The effect of treatment (none versus 1 mM CNO − versus 4 mM CNO − ) assessed by analysis of variance was significant for each condition (control P l 0n049, H 2 O 2 P 0n0001, PMA P 0n001, OZ P l 0n0067). A two-way analysis of variance of the effects of CNO − (P 0n0001) and condition (i.e. control, H 2 O 2 , PMA or OZ) (P 0n0001) on MPO activity also demonstrates highly significant CNO − dose-dependence of MPO inhibition.
Inhibitory effects of CNO − on MPO activity of intact PMNs
When isolated human PMNs are exposed to CNO − for 30 min and then washed, there is little decrease in PMN-associated MPO activity. However, MPO is inactivated when PMNs are exposed to exogenous H # O # , or stimulated by PMA or OZ, in the presence of CNO − (Figure 7) . Therefore this CNO − -mediated inactivation of MPO within intact PMNs evidently requires either exogenous H # O # or active production of H # O # by stimulated PMNs. These observations also imply that PMNs, as well as the azurophilic granules containing MPO, are permeable to exogenous CNO − . Previous results from our laboratory [20] indicate that such maximal PMA stimulation of PMNs for 30 min induces release of only about 3 % of total intracellular MPO. Therefore MPO inactivation occurs primarily within the azurophilic granules of the intact cells.
On the other hand, in contrast with earlier reports, we find that in PMNs exposed to CNO − , PMA-stimulated H # O # production is unaffected. Thus, as shown in Figure 8 , even high concentrations of CNO − have no effect on H # O # production by PMAstimulated PMNs, whereas relatively low concentrations of CNO − effectively block HOCl generation in duplicate samples of the same PMNs. Therefore it would appear that CNO − has little effect on the (O # − d\H # O # -generating) metabolism of PMAstimulated PMNs while specifically impairing MPO-dependent HOCl production.
Effects of CNO − on MPO-mediated bactericidal activity
In an attempt to assess the functional importance of CNO − -dependent MPO inhibition, we chose S. aureus as a target organism because PMN killing of this species is highly dependent on MPO activity [31, 32] . When bacterial suspensions are exposed to reagent HOCl for 10 min and then placed in 50 % trypticase soy broth (which will consume all residual HOCl), the half lethal dose of HOCl is about 3n8 µM as measured by MTT reduction, 
Figure 8 Effects of KOCN on oxidant production by PMA-stimulated PMNs
PMNs were suspended (at 0n5i10 6 cells/ml and 1n0i10 6 cells/ml for H 2 O 2 and HOCl assays respectively) in complete HBSS containing 10 mM added sodium phosphate at pH 7n4. The samples for the HOCl assay also contained 15 mM taurine and those for the H 2 O 2 assay contained 1 mM NaN 3 . The cells were preincubated with KOCN at the indicated concentrations for 5 min and then stimulated by addition of 100 nM PMA (final concentration). The incubation was carried out for 1 h at 37 mC. The accumulated H 2 O 2 and taurine chloramine were determined as described in the Materials and methods section. All samples were in triplicate, and results are expressed as meanspS.D. Control values for taurine chloramine accumulation were 21n4p4n9 nmol/h per 10 6 PMNs and for H 2 O 2 they were 88p4n6 nmol/h per 10 6
PMNs.
whereas even 1000-fold higher concentrations of H # O # cause no detectable killing. Important to the following experiments, when bacterial suspensions are challenged with HOCl in the presence of 0n125-2 mM CNO − the half lethal dose of HOCl is unaffected, indicating that these low levels of CNO − will not directly scavenge significant amounts of preformed HOCl.
As shown in Figure 9 , when bacteria are exposed to a nontoxic concentration of H # O # (100 µM) in the presence of added MPO (17 m-units\100 µl), more than 50 % of the organisms are killed. However, when increasing concentrations of CNO − are added before the addition of H # O # , MPO-mediated bactericidal activity is greatly reduced. The inhibitory effect of CNO − is evident at CNO − concentrations as low as 60 µM. Under these 
DISCUSSION
Two situations in which high levels of urea are present, within the urinary bladder especially during prolonged urinary stasis and in uraemia, are characterized by increases in susceptibility to bacterial infections. Whereas many predisposing factors are probably involved, in both these situations impaired phagocyte functions (especially diminished PMN oxidative activities and bacterial killing) have been invoked. As reviewed at the outset, the high osmolality of urine may inhibit PMN oxidative activity (especially as reflected by luminol-enhanced chemiluminescence), but the increased osmolality from inorganic salts per se may be of lesser importance than that contributed by urea [8] . Similar correlations between plasma urea concentrations and defective PMN oxidative activities\bacterial killing have been detected in patients with uraemia.
CNO − : a possible urea-derived inhibitor of bacterial killing
It was speculated earlier that cyanic acid (H$O$C&N) or its predominant isoform isocyanic acid (H$N%C%O), breakdown products of urea, might play a role in the intoxication of uraemia [33] . In aqueous solution, urea undergoes reversible conversion into CNO − and NH $ . At body temperature and physiological pH, about 0n5-0n75 % of urea (in a 1 M urea solution) would be present as CNO − at equilibrium [9] . There is good evidence, albeit much of it indirect, that the expected elevations in CNO − do occur in body fluids of uraemic humans and animals and in concentrated urine. Elevated plasma CNO − concentrations are present in nephrectomized rabbits [34] . CNO − , being nucleophilic, can also be detected via its reaction products with proteins. CNO − reacts with α-amino, ε-amino, thiol and hydroxy moieties of amino acids, peptides and proteins [10] . Such carbamoylation reactions are known to inactivate enzymes [10, 35] and alter protein stability [36] [37] [38] . Important to the present work, carbamoylated haemoglobin, presumably formed by reaction with urea-derived CNO − , has been found in patients with renal failure [39, 40] . In addition, Kraus et al. [11] have observed that PMN proteins from uraemic patients are modified by CNO − in i o.
CNO − irreversibly inhibits PMN MPO activity
Because CNO − is chemically related to thiocyanate (SCN − ), a known pseudohalide and preferred substrate for eosinophil peroxidase, lactoperoxidase and salivary peroxidase, we studied the interaction of CNO − with MPO. We find that, in the presence of H # O # , CNO − strongly inhibits MPO activities (both peroxidative and halogenating).
Both H # O # and HOCl will inactivate MPO under certain conditions [41] . In the absence of halide, low concentrations of H # O # convert native MPO into compound II, which can be reactivated by reducing agents. In the presence of Cl − , however, the enzyme may be inactivated irreversibly by its own product, HOCl, through destruction of the haem moiety (evident from the loss of haem absorption at 400-450 nm) as well as through the oxidation of critical amino acid residues. We find that MPO, in 
Implications for PMN function
In previous reports by others, CNO − at high concentrations inhibited glucose utilization (when present at 7n5 mM [43] ) and superoxide generation (at concentrations of 36-120 mM) by stimulated PMNs [11] . In contrast, we find that, at concentrations up to 10 mM, CNO − does not affect H # O # production by PMAstimulated PMNs. On the other hand, CNO − strongly inhibits PMN chlorinating activity at much lower concentrations, as measured by taurine chloramine formation (largely effected by released, extracellular MPO activity) and by ascorbic acid oxidation. We excluded the possibility that CNO − simply quenches chlorinating species (HOCl or taurine chloramine), thereby preventing taurine chloramine accumulation because :
(1) addition of NaOCl to solutions containing both taurine and KOCN results in stoichiometric taurine chloramine recovery ; (2) taurine chloramine does not react with CNO − at neutral pH (as determined by taurine chloramine spectral change and retention of oxidative potential). We therefore conclude that MPO is far more susceptible to CNO − inhibition than is the PMN NADPH oxidase system. Finally, to the extent that MPO activity is important in the bactericidal actions of PMNs, CNO − has the potential to impair bacterial killing. We find that, at neutral pH, 1-2 mM CNO − will almost completely prevent MPO-mediated killing of S. aureus.
Conclusion
In summary, CNO − , one likely component of so-called ' uraemic toxins ', irreversibly inactivates PMN MPO. The inactivation appears to be mechanism-based and requires the presence of H # O # , suggesting that MPO inhibition does not simply arise from direct carbamoylation by CNO − . If an enzymically generated form of ' activated ' CNO − (e.g. HOOCN) is produced, this reactive species has either a very short half-life or low oxidation potential, rendering MPO per se the preferential target of subsequent reactions. H # O # -dependent inactivation of MPO by CNO − occurs in the intracellular environment of activated PMNs, and such inactivation would probably diminish MPO-dependent bactericidal activity of PMNs. Indeed, we observe that relatively small amounts of added CNO − will prevent MPO\H # O # -mediated killing of at last one target organism, S. aureus. We speculate that impairment of PMN bactericidal capacity by CNO − may help explain both the high risk of urinary-tract infection associated with urinary stasis and perhaps the generalized increase in susceptibility to infection in uraemic patients.
